Fact CheckerSign in

NCT07870044Recruiting

Investigating Techniques to Enhance the Sense of Embodiment in Immersive Virtual Reality

Studio Dell'Embodiment In Ambienti Di Realtà Virtuale Immersiva

Source: ClinicalTrials.gov · Last updated 13 Oct 2026

Brief summary (registry, in English)

Embodiment is an important aspect of virtual reality because it affects how natural and engaging the experience feels and can influence performance and learning in VR-based applications, including rehabilitation \[McAnally \& Wallis, 2022\]. In VR, embodiment refers to the extent to which a person feels that a virtual body (avatar) is their own and under their control. It is typically described as having three components: sense of agency (feeling that one is causing the avatar's actions), body ownership (feeling that the avatar's body is one's own), and self-location (feeling located where the avatar is) \[Kilteni, Groten, \& Slater, 2012\]. While many VR systems aim to increase embodiment, there is limited evidence on which specific techniques are most effective-especially in people with acquired neurological injuries, in whom central nervous system damage may alter body perception and multisensory integration \[Guy, Normand, Jeunet-Kelway, \& Moreau, 2023\]. This study will compare several VR techniques that may enhance embodiment, including synchronized visual and tactile stimulation, heart-rate-based visual biofeedback, increased possibilities to actively control the avatar, and familiarity with the performed action. Participants will include healthy volunteers and individuals with acquired neurological injuries (spinal cord injury or stroke). Across three study days, participants will complete multiple short VR conditions while wearing physiological sensors, and after each VR condition, participants will complete questionnaires about their VR experience. The goal is to identify which VR techniques most effectively increase embodiment and whether embodiment-related responses differ between healthy participants and clinical groups.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
90 (estimated)
First submitted
6 Oct 2026
Start date
2 Feb 2026
Primary completion date
Aug 2028
Lead sponsor
IRCCS Eugenio Medea
Diseases
Stroke
NCT number
NCT07870044

What you commit to

  • Study type: Interventional
  • Planned participants: 90
  • From 2 Feb 2026 to the primary completion date, Aug 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of epilepsy or epileptic seizures

Other

  • Poor head control
  • Visual acuity not correctable with glasses

Who the study is looking for

  • Age 12 to 50 years
  • Typically developing participants (healthy volunteers) OR participants with spinal cord injury OR participants with history of stroke
  • Score ≥ 7 on the "Vocabulary" subtest of WISC (for minors) or WAIS (for adults)

Age in the registry: 12 years to 50 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS Eugenio Medea
Coordinator of this site? Confirm its status
Bosisio PariniItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.